Drug-induced pulmonary arterial hypertension: a recent outbreak (original) (raw)

Drug-induced pulmonary arterial hypertension: a review

Ghulam Akbar

Heart Failure Reviews, 2017

View PDFchevron_right

Drugs induced pulmonary arterial hypertension

David Montani

La Presse Médicale, 2013

View PDFchevron_right

Chapter 8 Drug-and Toxin-Induced Pulmonary Arterial Hypertension

Laura Price

View PDFchevron_right

Drug-associated pulmonary arterial hypertension

Nicholas Whitehead

Clinical toxicology (Philadelphia, Pa.), 2018

View PDFchevron_right

Temporal trends and drug exposures in pulmonary hypertension: An American experience

Alec Walker

American Heart Journal, 2006

View PDFchevron_right

Serotonin Signaling in Pulmonary Hypertension

M. Caestecker

Circulation Research, 2006

View PDFchevron_right

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

rogerio souza

European Respiratory Journal, 2008

View PDFchevron_right

PRX-08066, a Novel 5Hydroxytryptamine Receptor 2B Antagonist, Reduces Monocrotaline-Induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats

sean faris

Journal of Pharmacology and Experimental Therapeutics, 2010

View PDFchevron_right

Anorexigen-Associated Pulmonary Arterial Hypertension and the Serotonin Hypothesis: A Story Worth Telling

Sonja Bartolome

Advances in Pulmonary Hypertension

View PDFchevron_right

Practical Considerations for the Pharmacotherapy of Pulmonary Arterial Hypertension

Vincent Mauro

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012

View PDFchevron_right

Perspectives On Oral Pulmonary Hypertension Therapies Recently Approved by the Food and Drug Administration

Charles D Burger

Annals of the American Thoracic Society, 2013

View PDFchevron_right

Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives

Muriel Fartoukh

CHEST Journal, 1998

View PDFchevron_right

Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment

Juergen Burhenne

Respiration, 2017

View PDFchevron_right

Serotonin Transporter Inhibition Prevents and Reverses Monocrotaline-Induced Pulmonary Hypertension in Rats

Christophe Guignabert

Circulation, 2005

View PDFchevron_right

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

M. Canuet, F. Perros, A. Bourdin, X. Jais, Christophe Pison, Christophe Guignabert

Circulation, 2012

View PDFchevron_right

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report

Aivars Lejnieks

Journal of Medical Case Reports, 2017

View PDFchevron_right

Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice

Margaret Maclean

Circulation, 2008

View PDFchevron_right

Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation

Marc Abramowicz

European Respiratory Journal, 2003

View PDFchevron_right

Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults

Harold Palevsky

Chest, 2014

View PDFchevron_right

Rapid recurrence of pulmonary hypertension following cessation of nifedipine

Mark M Gallagher

Postgraduate Medical Journal, 1998

View PDFchevron_right

High Plasma Serotonin Levels in Primary Pulmonary Hypertension

philippe herve

Arteriosclerosis, Thrombosis, and Vascular Biology, 2000

View PDFchevron_right

Current Pharmacological Treatment of Pulmonary Arterial Hypertension

Paschalis Steiropoulos

Current Clinical Pharmacology, 2008

View PDFchevron_right

A disease looking for innovative drugs: The case of pulmonary arterial hypertension

Vittorio Bertele'

European Journal of Internal Medicine, 2018

View PDFchevron_right

Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension

Ali Sadoughi

Chest, 2013

View PDFchevron_right

Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension

Neil Hamilton, Charlie Elliot, Athanasios Charalampopoulos

The European respiratory journal, 2016

View PDFchevron_right

Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature

Chiara Nalli

Journal of Cardiology Cases

View PDFchevron_right

C-122, a novel antagonist of serotonin receptor 5-HT< sub> 2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats

Peter Senese

European Journal of …, 2011

View PDFchevron_right

Dexfenfluramine protects against pulmonary hypertension in rats

Yoshihide Mitani

Journal of applied physiology (Bethesda, Md. : 1985), 2002

View PDFchevron_right

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study

Christophe Guignabert

The European respiratory journal, 2017

View PDFchevron_right

Pulmonary Hypertension Associated with Use of Phentermine

Ji Yong Jang

Yonsei Medical Journal, 2010

View PDFchevron_right